PDAC - Pancreatic Ductal Adenocarcinoma Clinical Trials in Rochester, Minnesota
2 recruitingRochester, Minnesota
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Lung CancerNSCLCThoracic Cancer+5 more
Tango Therapeutics, Inc.183 enrolled18 locationsNCT06922591
Recruiting
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+1 more
Mayo Clinic5,000 enrolled1 locationNCT06151223